Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

Wren Laboratories

Other names: Wren Laboratories | Wren Laboratories LLC | Wren Laboratories, LLC | Wren Laboratories (Europe) Limited
Related tests:


Wren Laboratories’ new molecular diagnostic predicts patient response to Peptide Receptor Radionuclide Therapy with unprecedented accuracy (BioSpace)
"Wren’s PPQ, a companion test to Wren Laboratories’ NETest®, classifies patients as either a 'Responder' who will experience disease stabilization and have a longer time to disease progression (usually greater than 18 months after the end of PRRT treatment), or as a 'Non-responder,' who will have a shorter time until the disease progresses (usually less than 12 months after the start of PRRT)."
Clinical data
Wren Laboratories inks China distribution agreement for neuroendocrine tumor assay (Genomeweb)
"Wren Laboratories announced...that it finalized a distribution agreement with Kindstar Globalgene Technology to distribute Wren's blood-based neuroendocrine tumor NETest throughout China...Under the five-year agreement, Kindstar Global plans to conduct a pilot study at Peking Union Medical College and use the data in a nationwide educational campaign about the benefits and diagnostic efficacies of the NETest."
Licensing / partnership